Geertje van der Horst
4PUBLICATIONS
23CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|May 19, 2025
TCR-Based Therapy Directed against Kallikrein-Related Peptidase 4 Is Safe and Effective against Prostate Cancer.Rosa A van Amerongen, Sander Tuit, Dennis F G Remst
|Jun 17, 2021
Reovirus mutant jin-3 exhibits lytic and immune-stimulatory effects in preclinical human prostate cancer models.Arjanneke F van de Merbel, Geertje van der Horst, Maaike H van der Mark
|Nov 11, 2020
Patient-derived tumour models for personalized therapeutics in urological cancers.Arjanneke F van de Merbel, Geertje van der Horst, Gabri van der Pluijm
|Sep 08, 2020
Cationic amphiphilic drugs as potential anticancer therapy for bladder cancer.Geertje van der Horst, Arjanneke F van de Merbel, Eline Ruigrok
Pageof 1
Frequent Collaborators
3 joint publications
Arjanneke F van de Merbel
2 joint publications
Gabri van der Pluijm
1 joint publications
Diana J M van den Wollenberg
1 joint publications
Nadine van Montfoort
1 joint publications
Niven Mehra
1 joint publications
Minke Smits
1 joint publications
Jack A Schalken
1 joint publications
Wytske M van Weerden
1 joint publications
Rob C Hoeben
1 joint publications
Rosa A van Amerongen
